In Vitro Cytotoxicity Screening Test

In vitro cytotoxicity screening is the first-line biological safety test used to determine whether medical devices, biomaterials, and their extracts release substances harmful to living cells. Performed in accordance with ISO 10993-5 and equivalent standards such as GB/T 16886.5 and USP Chapter 87, the assay delivers fast, sensitive, and ethically responsible results that support regulatory submissions and product development. This article explains the test principle, sample types, testing items, methods, and typical applications of cytotoxicity screening.

Technical Overview

In vitro cytotoxicity screening is a cell-culture-based laboratory test that evaluates whether a test article, or chemical substances extracted from it, adversely affects the viability, morphology, proliferation, or metabolic activity of cultured mammalian cells. It is the cornerstone of biological safety evaluation and is typically the first biocompatibility test performed on any new material or device before further in vitro or in vivo studies are planned.

The test is governed internationally by ISO 10993-5 (Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity), with sample preparation requirements defined in ISO 10993-12. In China, the technically equivalent national standard is GB/T 16886.5, while the United States Pharmacopeia General Chapter 87 (Biological Reactivity Tests, In Vitro) provides a compendial method widely used for plastics and elastomeric closures. The overall testing strategy is framed by ISO 10993-1 within a risk management process.

The screening is performed by accredited third-party laboratories and in-house biosafety facilities using well-characterized cell lines, most commonly L929 mouse fibroblasts. Compared with animal tests, the method is rapid, highly sensitive, reproducible, and cost-effective, and it plays a central role in reducing, refining, and replacing animal experimentation in biological safety assessment.

Testing Samples

Medical Devices and Device Components

Catheters, syringes, hypodermic needles, infusion and transfusion sets, cannulae, tubing, device housings, connectors, orthopedic and dental implants, cardiovascular implants, wound dressings, surgical drapes, contact lenses, intraocular lenses, and sterilization packaging components can all be evaluated, either as finished devices or as representative coupons of the final product.

Raw Materials and Biomaterials

Polymeric materials such as silicone, PVC, polyurethane, PEEK, and biodegradable polymers; metals and alloys including titanium, cobalt-chromium, and stainless steel; ceramics; hydrogels; bioadhesives; surface coatings; colorants and additives; and feedstock materials for 3D-printed or additive-manufactured products.

Extracts, Leachables, and Process-Related Samples

Liquid test articles, conditioned extraction media, process fluids, sterilant residues such as ethylene oxide by-products, cleaning agent residues, mold release agents, primary packaging materials, and leachables from drug-device combination products.

Cosmetics, Chemicals, and Consumer Products

Cosmetic ingredients and finished formulations, food contact materials, textiles, household chemical products, disinfectants, and engineered nanomaterials may also be screened using adapted cell-culture protocols.

Testing Items

Depending on the selected protocol and the information required, cytotoxicity screening can measure the following biological endpoints:

• Cell viability quantified by tetrazolium reduction assays such as MTT, XTT, WST-1, and CCK-8
• Cell proliferation assessed by direct cell counting, BrdU incorporation, or colony formation assays
• Cell membrane integrity evaluated by lactate dehydrogenase (LDH) release, neutral red uptake, or trypan blue exclusion
• Mitochondrial and metabolic activity monitored by resazurin or alamar blue reduction
• Morphological alterations observed and graded by phase-contrast microscopy
• Apoptosis and cell damage markers, such as caspase activity or annexin V staining, where mechanistic information is required

Results are reported as quantitative viability percentages relative to controls, qualitative reactivity grades, or both, together with statistical evaluation and photographic documentation.

Testing Methods

ISO 10993-5 defines three categories of cytotoxicity tests: the extract (elution) test, the direct contact test, and the indirect contact test. The choice depends on the nature of the sample, its intended use, and the expected release of extractable substances, and must be justified within the biological evaluation plan.

Extract (Elution) Test

The sample is prepared according to ISO 10993-12 using defined ratios of surface area or mass to extraction volume, for example 3 cm²/mL for flat polymer surfaces or 0.1–0.2 g/mL for irregular solids. Extraction is performed in complete culture medium containing serum at 37°C for 24 hours, or under accelerated conditions such as 50°C for 72 hours or 70°C for 24 hours. The resulting extract is applied to a confluent monolayer of L929 fibroblasts, typically in 96-well plates, and the endpoint is measured after 24 hours of exposure.

Direct Contact Test

The test sample is placed directly onto the cell monolayer with a minimal volume of medium to maximize contact. This method offers high sensitivity and is well suited to dense, solid materials with limited extractables. After 24 to 48 hours of contact, the zone of cell lysis or morphological change beneath and around the sample is microscopically graded.

Indirect Contact Tests (Agar Diffusion and Filter Diffusion)

In the agar diffusion assay, cells are overlaid with a thin layer of agarose before the sample is placed on top, so that leachable substances diffuse through the agar while mechanical damage is avoided. It is suitable for elastomers, latex items, and high-density materials. In the filter diffusion assay, cells are grown on a membrane filter that is inverted onto the sample, an approach used for materials that cannot withstand agar contact, such as those that liquefy or dissolve.

Quantitative Readout and Data Interpretation

In the quantitative MTT assay, metabolically active cells reduce yellow MTT to purple formazan crystals, which are solubilized and measured spectrophotometrically at 570 nm with a 650 nm reference wavelength. Viability is calculated as the absorbance of treated cells relative to the blank control. According to ISO 10993-5, a viability value of 70 percent or greater indicates that the sample has no cytotoxic potential under the test conditions, while values below 70 percent signal cytotoxic activity requiring further investigation.

Qualitative results are graded on a reactivity scale from 0 to 4, corresponding to none, slight, mild, moderate, and severe reactivity. Each test includes a negative control such as high-density polyethylene and a positive control such as zinc dibutyldithiocarbamate or a detergent solution to verify assay sensitivity. The test is valid only when controls perform within predefined acceptance criteria.

Applications

In vitro cytotoxicity screening supports product safety across the full life cycle of medical and consumer products, from research and development to market release and post-market change control.

• Regulatory biocompatibility files for CE marking under the EU Medical Device Regulation, FDA 510(k) and PMA submissions, NMPA registration in China, and PMDA submissions in Japan
• Material selection, formulation optimization, and comparative screening during early-stage R&D
• Change control evaluation following modifications to materials, suppliers, manufacturing processes, or sterilization methods
• Routine quality control and batch release testing for high-risk product families
• Assessment of sterilization residuals, cleaning agents, and packaging-related leachables
• Screening support for cosmetic and chemical safety programs as an alternative to animal acute toxicity studies
• Leachables and extractables investigation for drug-device combination products and drug delivery systems

FAQ

Which standards govern in vitro cytotoxicity screening?

The primary standard is ISO 10993-5, supported by ISO 10993-12 for sample preparation and ISO 10993-1 for the overall evaluation strategy. In China, GB/T 16886.5 is the equivalent national standard, and USP Chapter 87 provides a compendial in vitro method recognized in pharmaceutical and medical device contexts.

Which cell lines are commonly used?

L929 mouse fibroblasts are the most widely used and recommended line. BALB/c 3T3, NIH/3T3, V79, MRC-5, and HepG2 cells may be selected for specific study designs. Cells are cultured at 37°C in a humidified atmosphere containing 5 percent carbon dioxide.

What is the pass criterion?

For quantitative assays, a cell viability of 70 percent or greater relative to the blank control indicates no cytotoxic potential under the conditions of the test. For qualitative assays, a reactivity grade of 0 or 1 is generally regarded as acceptable, with higher grades requiring further evaluation.

How is the test method selected?

The extract test is the most versatile and is preferred for most devices and materials. Direct contact suits dense materials with low extractable levels, while agar or filter diffusion suits elastomers and heat-sensitive items. The rationale for method selection must be documented within the biological evaluation plan.

How much sample is required and how long does testing take?

The required quantity is determined by the extraction ratios defined in ISO 10993-12, typically several grams or tens of square centimeters per extraction condition, tested in duplicate. Standard screening, including extraction, cell exposure, and readout, is usually completed within one to three weeks.

Does a passing result replace animal testing?

A negative cytotoxicity result supports the biological safety rationale and, together with other in vitro data such as irritation testing under ISO 10993-23, can justify a reduction in animal testing under a documented risk assessment. However, it does not automatically substitute for all in vivo endpoints, and the overall conclusion must follow the ISO 10993-1 evaluation framework.